Gene · 835
Papers3,745
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 3,745
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Targeting NEDD8-activating enzyme for cancer therapy: developments, clinical trials, challenges and future research directions. | J Hematol Oncol | 2023 | 37525282 | PubTator, text mining | PubMed |
| Functional polymorphism in miR-208 is associated with increased risk for ischemic stroke. | BMC Med Genomics | 2023 | 37525251 | PubTator, text mining | PubMed |
| PANoptosis-related molecular subtype and prognostic model associated with the immune microenvironment and individualized therapy in pancreatic cancer. | Front Oncol | 2023 | 37519797 | PubTator, text mining | PubMed |
| The transcriptional landscape of endogenous retroelements delineates esophageal adenocarcinoma subtypes. | NAR Cancer | 2023 | 37502711 | PubTator, text mining | PubMed |
| The solute carrier SPNS2 recruits PI(4,5)P2 to synergistically regulate transport of sphingosine-1-phosphate. | Mol Cell | 2023 | 37499662 | PubTator, text mining | PubMed |
| The roles of inflammasomes in cancer. | Front Immunol | 2023 | 37497237 | PubTator, text mining | PubMed |
| Caspase-mediated LPS sensing and pyroptosis signaling in Hydra. | Sci Adv | 2023 | 37478191 | PubTator, text mining | PubMed |
| Autoimmune limbic encephalitis combined with leptomeningeal metastases of non-small cell lung cancer: treatment response to osimertinib, immunoglobulin, rituximab, and tocilizumab. | Encephalitis | 2023 | 37469717 | PubTator, text mining | PubMed |
| Structural basis for specific RNA recognition by the alternative splicing factor RBM5. | Nat Commun | 2023 | 37454201 | PubTator, text mining | PubMed |
| An electrophilic fragment screening for the development of small molecules targeting caspase-2. | Eur J Med Chem | 2023 | 37453329 | PubTator, text mining | PubMed |
| BID expression determines the apoptotic fate of cancer cells after abrogation of the spindle assembly checkpoint by AURKB or TTK inhibitors. | Mol Cancer | 2023 | 37443114 | PubTator, text mining | PubMed |
| MOViDA: multiomics visible drug activity prediction with a biologically informed neural network model. | Bioinformatics | 2023 | 37432499 | PubTator, text mining | PubMed |
| Where should siRNAs go: applicable organs for siRNA drugs. | Exp Mol Med | 2023 | 37430086 | PubTator, text mining | PubMed |
| Oncogenic SRSF3 in health and diseases. | Int J Biol Sci | 2023 | 37416784 | PubTator, text mining | PubMed |
| Uncoupling hepatic insulin resistance - hepatic inflammation to improve insulin sensitivity and to prevent impaired metabolism-associated fatty liver disease in type 2 diabetes. | Front Endocrinol (Lausanne) | 2023 | 37396181 | PubTator, text mining | PubMed |
| Mechanisms involved in the HMGB1 modulation of tumor multidrug resistance (Review). | Int J Mol Med | 2023 | 37387415 | PubTator, text mining | PubMed |
| A signature based on anoikis-related genes for the evaluation of prognosis, immunoinfiltration, mutation, and therapeutic response in ovarian cancer. | Front Endocrinol (Lausanne) | 2023 | 37383389 | PubTator, text mining | PubMed |
| β-Lapachone Exerts Anticancer Effects by Downregulating p53, Lys-Acetylated Proteins, TrkA, p38 MAPK, SOD1, Caspase-2, CD44 and NPM in Oxaliplatin-Resistant HCT116 Colorectal Cancer Cells. | Int J Mol Sci | 2023 | 37373014 | PubTator, text mining | PubMed |
| Prognostic, Immunological, and Mutational Analysis of MTA2 in Pan-Cancer and Drug Screening for Hepatocellular Carcinoma. | Biomolecules | 2023 | 37371463 | PubTator, text mining | PubMed |
| MiRNA-Based Therapies for Lung Cancer: Opportunities and Challenges? | Biomolecules | 2023 | 37371458 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/835/papers?page=10